Bioassays for evaluation of medical products derived from bacterial toxins

Curr Opin Microbiol. 2012 Jun;15(3):310-6. doi: 10.1016/j.mib.2012.05.008. Epub 2012 May 29.

Abstract

Bioassays play central role in evaluation of biological products and those derived from bacterial toxins often rely exclusively on in vivo models for assurance of safety and potency. This chapter reviews existing regulatory approved methods designed to provide information on potency and safety of complex biological medicines with an insight into strategies considered for alternative procedures.

Publication types

  • Review

MeSH terms

  • Animals
  • Bacterial Toxins / pharmacology*
  • Bacterial Toxins / standards
  • Bacterial Toxins / toxicity
  • Bacterial Vaccines / pharmacology
  • Bacterial Vaccines / standards
  • Bacterial Vaccines / toxicity
  • Biological Assay / standards
  • Cell Line
  • Humans

Substances

  • Bacterial Toxins
  • Bacterial Vaccines